SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-134076
Filing Date
2022-04-29
Accepted
2022-04-29 16:52:31
Documents
13
Period of Report
2022-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d638762d8k.htm   iXBRL 8-K 24304
2 EX-99.1 d638762dex991.htm EX-99.1 7694
  Complete submission text file 0001193125-22-134076.txt   153092

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zsan-20220429.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20220429_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20220429_pre.xml EX-101.PRE 10823
7 EXTRACTED XBRL INSTANCE DOCUMENT d638762d8k_htm.xml XML 3264
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 22876732
SIC: 2834 Pharmaceutical Preparations